Correlation Between Valneva SE and Verona Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Valneva SE and Verona Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Valneva SE and Verona Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Valneva SE ADR and Verona Pharma PLC, you can compare the effects of market volatilities on Valneva SE and Verona Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Valneva SE with a short position of Verona Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Valneva SE and Verona Pharma.

Diversification Opportunities for Valneva SE and Verona Pharma

-0.82
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Valneva and Verona is -0.82. Overlapping area represents the amount of risk that can be diversified away by holding Valneva SE ADR and Verona Pharma PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Verona Pharma PLC and Valneva SE is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Valneva SE ADR are associated (or correlated) with Verona Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Verona Pharma PLC has no effect on the direction of Valneva SE i.e., Valneva SE and Verona Pharma go up and down completely randomly.

Pair Corralation between Valneva SE and Verona Pharma

Given the investment horizon of 90 days Valneva SE ADR is expected to under-perform the Verona Pharma. But the stock apears to be less risky and, when comparing its historical volatility, Valneva SE ADR is 1.26 times less risky than Verona Pharma. The stock trades about -0.46 of its potential returns per unit of risk. The Verona Pharma PLC is currently generating about 0.19 of returns per unit of risk over similar time horizon. If you would invest  3,386  in Verona Pharma PLC on August 26, 2024 and sell it today you would earn a total of  495.00  from holding Verona Pharma PLC or generate 14.62% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Valneva SE ADR  vs.  Verona Pharma PLC

 Performance 
       Timeline  
Valneva SE ADR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Valneva SE ADR has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's essential indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.
Verona Pharma PLC 

Risk-Adjusted Performance

16 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Verona Pharma PLC are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Verona Pharma sustained solid returns over the last few months and may actually be approaching a breakup point.

Valneva SE and Verona Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Valneva SE and Verona Pharma

The main advantage of trading using opposite Valneva SE and Verona Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Valneva SE position performs unexpectedly, Verona Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Verona Pharma will offset losses from the drop in Verona Pharma's long position.
The idea behind Valneva SE ADR and Verona Pharma PLC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.

Other Complementary Tools

Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk